Blog

Blueprint Medicines shells out nearly $500M for San Diego cancer startup

img4069-edit900xx3264-2176-0-136

Blueprint Medicines Inc. is paying nearly half a million dollars to buy a San Diego-based cancer startup called Lengo Therapeutics.

Read More